|
|
Document ActionsLupuzor deal lifts Immupharma
by
—
last modified
Nov 26, 2008
Shares in Immupharma, the biotechnology group, rose almost 30 per cent after it signed an option agreement with Cephalon, the US pharmaceutical company, to outlicense...
Source available
here
|
|
Forgotten your Password?
Register?
